A Phase 1, Open-label, Multiple-probe Drug-drug Interaction Study to Determine the Effect of Rucaparib on Pharmacokinetics of Caffeine, S-Warfarin, Omeprazole, Midazolam, and Digoxin in Patients With Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 08 Mar 2017
At a glance
- Drugs Rucaparib (Primary) ; Caffeine; Digoxin; Midazolam; Omeprazole; Vitamin K; Warfarin
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Clovis Oncology
- 01 Mar 2017 Planned End Date changed from 1 Apr 2017 to 1 Sep 2017.
- 01 Mar 2017 Planned primary completion date changed from 1 Oct 2016 to 1 Mar 2017.
- 19 Apr 2016 New trial record